We comply with insider trading laws
In the course of our jobs, we may hear or know about a company’s business activities or plans that are not yet publicized.
Information that has not been made public, but if known, may persuade a reasonable investor to buy, sell or hold a company’s securities is called “inside” or “nonpublic” information. Never use this information – whether it is about AbbVie or any other company — to conduct a trade. Never “tip” someone else on what you know so that they may trade. Insider trading and tipping are illegal.
- Mergers or acquisitions
- Changes in management
- Financial results or forecasts
- Market strategies
- Legal actions
- Contracts
- Clinical trial or other scientific data
There are many kinds of material, nonpublic information.
It could be anything you know about current, new or pending… Even after inside information is made public, you are not allowed to use the information to trade in securities until a certain amount of time has elapsed. Contact our Legal Department if you have any questions about a transaction you are considering.
Making a difference
My neighbor works for one of AbbVie’s collaboration partners and tells me that important clinical trial data for a compound being developed jointly by her employer and AbbVie will be released next week. The data suggests that the compound will be highly successful commercially. I think about purchasing the collaboration partner’s stock and telling my brother, but realize that what I have heard about both companies could be considered material, nonpublic information. I keep the information confidential and do not trade in either company’s stock so as not to violate our Code or the law.
- Learn More
See our Insider Training in Securities policy or contact Legal for additional information.
